Genetic and epigenetic regulation and expression signatures of glutathione S-transferases in developing mouse liver.
The hepatic glutathione S-transferases (Gsts) are critical phase II enzymes in protecting cellular macromolecules against electrophiles and oxidative stress. Little is known about the ontogeny of Gsts and the underlying regulatory mechanisms during liver development. Therefore, in this study, the ontogeny and the regulatory mechanisms of 19 known Gst isoforms were investigated in mouse liver from 2 days before birth to postnatal day 45. With the exception of Gstm5 and MGst2 that showed a progressive decline in postnatal messenger RNA (mRNA) expression, most other Gst isoforms showed a progressive increase in postnatal mRNA expression. Two-way hierarchical clustering revealed three distinct expression patterns of these Gsts isoforms: perinatal, adolescent, and adult enriched. The expression signatures of certain Gst isoforms showed positive association with the ontogeny of critical xenobiotic-sensing transcription factors, including aryl hydrocarbon receptor, pregnane X receptor (PXR), constitutive androstane receptor, peroxisome proliferator-activated receptor alpha, and NF-E2-related factor-2. Specifically, genome-wide chromatin immunoprecipitation coupled with the next generation sequencing technology (ChIP-Seq) revealed direct PXR-binding sites to the Gsta, Gstm, Gstt, and Gstp polycistron clusters as well as to the Mgst1 gene locus. Chromatin immunoprecipitation-on-chip analysis demonstrated that DNA methylation and histone H3K27-trimethylation (H3K27me3), two-gene expression-suppressing epigenetic marks, were consistently low around the Gstz1 gene locus. In contrast, enrichment of histone H3K4-dimethylation (H3K4me2), a hallmark for gene activation, increased 60% around the Gstz1 gene locus from prenatal to the young adult period. Regression analysis revealed a strong correlation between the enrichment of H3K4me2 and Gstz1 mRNA expression (r = 0.76). In conclusion, this study characterized three distinct ontogenic expression signatures of the 19 Gst isoforms and examined some genetic and epigenetic mechanisms inducing their transcription during liver development.
Cui
Julia Yue
JY
Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas 66160, USA. ycui@kumc.edu
Choudhuri
Supratim
S
Knight
Tamara R
TR
Klaassen
Curtis D
CD
D000818:Animals; D044127:Epigenesis, Genetic; D005260:Female; D018507:Gene Expression Regulation, Developmental; D015971:Gene Expression Regulation, Enzymologic; D005982:Glutathione Transferase / Q000235:genetics*; D008099:Liver / Q000196:embryology / Q000201:enzymology* / Q000254:growth & development; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D012333:RNA, Messenger / Q000235:genetics
D012333:RNA, Messenger; D005982:Glutathione Transferase
Biomed Pharmacother. 2009 Feb;63(2):79-85
18819770
Carcinogenesis. 2002 Mar;23(3):457-62
11895860
Toxicol Sci. 2009 Oct;111(2):238-46
19474220
Endocr Rev. 2002 Oct;23(5):687-702
12372848
Mol Endocrinol. 2005 Mar;19(3):595-606
15563547
Pharmacol Toxicol. 1998 May;82(5):209-17
9646325
Drug Metab Dispos. 2002 Feb;30(2):212-9
11792693
J Pharmacol Exp Ther. 2002 May;301(2):551-60
11961056
Stem Cells Dev. 2008 Aug;17(4):775-83
18752429
FASEB J. 1994 Jan;8(1):36-42
7905448
Nat Genet. 2003 Mar;33 Suppl:245-54
12610534
Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):15782-7
17043231
Biochem J. 1992 Feb 15;282 ( Pt 1):209-18
1540137
Nature. 2006 May 18;441(7091):349-53
16625203
Crit Rev Biochem Mol Biol. 1995;30(6):445-600
8770536
Genes Dev. 2002 Jan 1;16(1):6-21
11782440
Toxicol Lett. 2009 Sep 28;189(3):184-90
19481593
Toxicol Sci. 2008 Dec;106(2):329-38
18723825
Mol Pharmacol. 1990 Oct;38(4):462-70
2233688
Hum Reprod. 2001 Nov;16(11):2445-50
11679536
Hum Mol Genet. 2006 Apr 15;15 Spec No 1:R1-7
16651365
Mol Cell Biol. 1986 Aug;6(8):2969-76
3785219
Nature. 2007 May 24;447(7143):425-32
17522676
Cell. 2006 Apr 21;125(2):301-13
16630818
Biochem Biophys Res Commun. 2007 Jun 8;357(3):575-8
17434454
Toxicol Sci. 2007 Dec;100(2):513-24
17890767
Cell. 2007 May 18;129(4):823-37
17512414
Biochem J. 1997 Dec 15;328 ( Pt 3):929-35
9396740
Nature. 2005 Aug 11;436(7052):876-80
15988478
Dev Dyn. 2007 Apr;236(4):1144-56
17304537
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13801-6
12370413
Eur J Biochem. 1991 Apr 10;197(1):145-53
2015817
Biochem J. 1994 Mar 1;298 ( Pt 2):385-90
8135745
J Pharmacol Exp Ther. 2002 Apr;301(1):145-51
11907168
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12457-62
16895995
Cell. 2005 Jan 28;120(2):169-81
15680324